Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its receptor, and coding sequence

Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its receptor, and coding sequence

US Patent 9580498 · Granted Feb 28, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Computer-automated systems and methods for using language models to generate tex2025
Integrated silicon photonics transceivers enabling ultra-high-speed high dense i2025
Device-to-device wireless communication2025
Method and apparatus for linear frequency modulation of large dynamic range with2025
High-reliability flight case with auxiliary locking function2025
Method for differentiable architecture search based on a hierarchical grouping m2025
Traveling waveguide in Mach-Zehnder modulator to facilitate phase match and impe2025
Monoclonal antibody specifically binding human and monkey CD38 antigens, prepara2024
Monoclonal antibody specifically binding human and monkey CD38 antigens, prepara2024
Monoclonal antibody specifically binding human and monkey CD38 antigens, prepara2024
Monoclonal antibody specifically binding human and monkey CD38 antigens, prepara2024
Face recognition method based on evolutionary convolutional neural network2024